Skip to main content

Table 2 Background variables in the different studies

From: The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials

Author

Schrader et al. [11]

Tronvik et al. [12]

Stovner et al. [13]

Hagen et al. [14]

All

Publication year

2001

2003

2014

2015

Number included

60

60

72

72

264

Mean age (SD)

41.1 (10.2)

42.9 (12.0)

37.3 (10.7)

38.9 (12.3)

39.9 (11.5)

Female sex, n (%)

50 (83.3)

47 (78.3)

59 (81.9)

63 (87.5)

219 (83.0)

Migraine with aura, n (%)

27 (45.0)

28 (46.7)

33 (45.8)

23 (31.9)

111 (42.0)

Mean BMI (SD)

24.3 (4.4)

25.3 (4.3)

NA1

24.4 (3.7)

24.7 (4.1)

Mean age at first migraine attack (SD)

17.1 (7.7)

19.6 (9.1)

17.9 (10.7)

20.1 (9.3)

18.7 (9.3)

Mean self-reported frequency of migraine attacks/months (SD)

4.3 (1.6)

3.7 (1.2)

4.8 (3.6)

3.6 (1.6)

4.1 (2.3)

Mean migraine days/4 weeks (SD)

6.6 (3.4)

5.7 (2.9)

5.3 (3.1)

5.3 (2.3)

5.7 (2.9)

Mean headache days/4 weeks (SD)

9.7 (5.2)

8.4 (3.9)

8.2 (4.3)

6.4 (2.8)

8.1 (4.2)

  1. 1Not available